MED Institute Joins Novelna’s PULSE Consortium to Advance Wearable Biosensing Technology for Post-Heart Attack Monitoring MED Institute has joined Novelna Inc. and its consortium partners in the development of the…
Portal Innovations Report Highlights Capital Efficiency and Growth Potential in Emerging U.S. Biotech Hubs Portal Innovations has announced the release of Biotech’s Next Frontier: Emerging Hubs Built for Efficiency and…
Baszucki Group Funds UAB Study Evaluating Ketogenic Therapy for Bipolar Disorder in Rural Alabama Baszucki Group has announced funding for a new clinical study investigating the potential psychiatric and metabolic…
Doctors and Public Health Experts Call for Oral Health to Be Integrated Into Everyday Healthcare Doctors, public health specialists and dental professionals are urging governments, healthcare systems and medical practitioners…
BrightFocus Foundation’s $330 Million Research Investment Generates Eightfold Increase in Follow-On Funding, Assessment Finds BrightFocus Foundation, a nonprofit organization dedicated to advancing research into Alzheimer’s disease, macular degeneration, and glaucoma,…
Kazmira Therapeutics Partners With CareValidate to Expand Access to Prescription, THC-Free CBD Therapy Across the U.S. Kazmira Therapeutics, the company behind Kazmira Pharmacy and the Cope Now telehealth platform, has…
Proteintech Appoints Patrick Yount as CFO and Promotes Jeb Gaybrick to Lead Corporate Strategy and Investor Relations Proteintech Group, Inc., a global life sciences company, has announced two leadership changes…
Curi Bio Expands Curiverse With New Disease Models, 3D Tissue Casting Kits and Advanced Drug Discovery Assays Curi Bio, a biotechnology company developing advanced human-relevant research tools for drug discovery,…
Medicinal Genomics Launches Rapid Pathogen Testing Solution for Dietary Supplement Manufacturers Medicinal Genomics has launched a rapid microbial testing solution designed to help dietary supplement manufacturers identify key foodborne and…
Cure First to More Than Double PARIS Test Capacity, Expanding Functional Precision Medicine Access for Patients With Difficult-to-Treat Cancers Cure First, a Seattle-based 501(c)(3) nonprofit organization focused on expanding access…
Immunis Named Semifinalist in National Academy of Medicine’s Healthy Longevity Global Competition for Muscle Health Innovation Immunis, Inc., a clinical-stage biotechnology company developing multi-active biologics designed to restore muscle health…
GC Biopharma to Present New IVIG Product Analyses and Host Patient Advocacy Symposium at IgNS 2026 Conference GC Biopharma USA, Inc., a company specializing in plasma-derived products, has announced plans…